ArticleCancer gene therapy2005

RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis.

Riccardo Taulli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.